After eight years of clinical trials and tests, and approximately two decades of use in other countries, the Food and Drug Administration finally approved mifepristone (originally known as RU 486) in September 2000 for use as a non-surgical, early abortion option.  The drug represents a significant step forward in American women's reproductive health.  Now, having failed to block mifepristone's approval, anti-choice lawmakers and advocates have mounted a multi-front campaign against the drug.

Click here to download a printable PDF of the entire document.